Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Citing underutilized capacity, Roche has announced a major overhaul of its drug chemical manufacturing network. In a move that will affect 1,200 jobs, the Swiss pharma firm is shedding four sites, located in Clarecastle, Ireland; Leganés, Spain; Segrate, Italy; and Florence, S.C. Roche will meanwhile sink roughly $300 million into a site in Kaiseraugst, Switzerland, to support novel manufacturing technology. Roche, which hopes to find a buyer for the facilities, expects restructuring costs will total $1.6 billion between 2016 and 2021. As it pares back its small-molecule manufacturing, Roche notes that it has put more than $2 billion into biologics manufacturing capacity in the past two years.
This article has been sent to the following recipient: